Expert Insights on Japanese Pharmaceutical Industry Trends

Despite being the second largest pharmaceutical market in 2008, Japan has experienced a lower growth rate than other major pharmaceutical markets, with the government’s imposed price control serving as a key contributing factor.

Get expert insights on:

M&A activity and overall consolidation in the Japanese pharmaceutical market
Market entry of generic manufacturers
Pricing and reimbursement in Japan

Engage an Expert on Japanese Pharmaceutical Industry ...

Gerson Lehrman Group Council Members are available to discuss Japanese Pharmaceutical Industry Trends via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manage^SM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Nitin Naik

Vice PresidentFROST & SULLIVAN, INC

Nitin Naik

Vice PresidentFROST & SULLIVAN, INC

Peter Gensheimer

DirectorSAVILLS JAPAN K.K.

Peter Gensheimer

DirectorSAVILLS JAPAN K.K.

George Kaadi

VP & Chief Information OfficerSOMPO JAPAN INSURANCE COMPANY OF AMERICA

Browse all 364 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name	No. Members
Ophthalmologists (Japan)	11
Ophthalmologists (Japan)	11
Internal Medicine Physicians (Japan)	105
Obstetricians/Gynecologists (Japan)	10
Internal Medicine Physicians (Japan)	105